Cellistic
  • Platforms
    • Pulse
    • Echo
      • Echo - NK
  • Allo Chassis™
  • Our Approach
    • Donor-Derived Allogeneic
    • iPSC-Based Allogeneic
    • Autologous
  • News & Events
    • Insights
    • Events
  • About
    • Team
    • Facility
    • Careers
  • Contact
Cellistic Launches Echo™ – NK Platform, a Scalable Solution for Off-the-Shelf Allogeneic Immune Cell Therapies Cellistic Launches Echo™ – NK Platform, a Scalable Solution for Off-the-Shelf Allogeneic Immune Cell Therapies

Cellistic Launches Echo™ – NK Platform, a Scalable Solution for Off-the-Shelf Allogeneic Immune Cell Therapies

Belgium, Mont Saint-Guibert, April 10 – Cellistic, a pioneer in induced pluripotent stem cells (iPSC)-based ...


April 10, 2025

Cellistic launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell Lines facilitating cost-effective cell therapy development

Cellistic launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell Lines facilitating cost-effective cell therapy development

February 17, 2025

iPSC-Derived Allogeneic Cell Therapies and Cloaking: Mechanisms, Importance and Strategies

iPSC-Derived Allogeneic Cell Therapies and Cloaking: Mechanisms, Importance and Strategies

February 5, 2025

Development and characterization of iPSC-derived regulatory T cells – Towards an allogenic cell therapy for the treatment of autoimmunity and inflammatory conditions

Development and characterization of iPSC-derived regulatory T cells – Towards an allogenic cell therapy for the treatment of autoimmunity and inflammatory conditions

December 3, 2024

Announcements Events Expert Opinion Interviews Podcasts Posters Webinars

Announcements

See all
Cellistic Launches Echo™ – NK Platform, a Scalable Solution for Off-the-Shelf Allogeneic Immune Cell Therapies

April 10, 2025

Cellistic Launches Echo™ – NK Platform, a Scalable Solution for ...

Belgium, Mont Saint-Guibert, April 10 – Cellistic, a pioneer in induced pluripotent stem cells ...

Cellistic Announces the Appointment of Tarran Pierfelice as New Chief Commercial Officer

March 10, 2025

Cellistic Announces the Appointment of Tarran Pierfelice as New Chief ...

Mont-Saint-Guibert, Belgium (March 10, 2025) – Cellistic is pleased to announce the ...

Cellistic launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell Lines facilitating cost-effective cell therapy development

February 17, 2025

Cellistic launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell ...

Belgium, Mont Saint-Guibert, February 17 – Cellistic, a pioneer in iPSC-based off-the-shelf ...

Posters

Using iPSC and gene editing technologies to generate immune-cloaked “off-the-shelf” allogeneic cell therapies

October 26, 2023

Using iPSC and gene editing technologies to generate immune-cloaked ...

Using iPSC and gene editing technologies to generate immune-cloaked "off-the-shelf" allogeneic ...

Events

See all
ATW 2024: Looking Ahead in Cell & Gene Therapy

February 12, 2024

ATW 2024: Looking Ahead in Cell & Gene Therapy

Our team returned from Advanced Therapies Week 2024 in Miami energized and excited about the ...

ESGCT 2023: Defining the Future of Cell & Gene Therapy

November 8, 2023

ESGCT 2023: Defining the Future of Cell & Gene Therapy

The ESCGT 30th Annual Congress was once again filled with the pioneering research and idea ...

Three key insights from the ISSCR Annual Meeting in Boston

August 2, 2023

Three key insights from the ISSCR Annual Meeting in Boston

The future of stem cell research starts here, at the ISSCR Annual Meeting, where more than ...

Expert Opinion

See all
Scaling NK Cell manufacturing: From iPSCs to NK cells in a feeder-free, GMP-ready platform

April 16, 2025

Scaling NK Cell manufacturing: From iPSCs to NK cells in a feeder-free, ...

Natural Killer (NK) cell treatments are not readily accessible to patients due to persistent ...

Accelerating iPSC Allogeneic Cell Therapy Development: The Role of Allo Chassis™

March 27, 2025

Accelerating iPSC Allogeneic Cell Therapy Development: The Role of Allo ...

Introduction Cell therapies have surged to the forefront of modern medicine, primarily due to ...

GMP Principles in iPS Cell Line Development: A Key Foundation for Advancing Therapeutic Applications

February 17, 2025

GMP Principles in iPS Cell Line Development: A Key Foundation for ...

Introduction The manufacture of Advanced Therapy Medicinal Products (ATMPs) requires the ...

Interviews

See all
Expert Opinion: Suzanne Snellenberg, PhD

July 18, 2023

Expert Opinion: Suzanne Snellenberg, PhD

Editor's note: In this installment of Expert Opinion, Suzanne Snellenberg, PhD, Director of ...

Sustaining momentum in iPSC-derived allogeneic cell therapies

March 30, 2023

Sustaining momentum in iPSC-derived allogeneic cell therapies

As published in Drug Target Review - March/April 2023 Issue Drug Target Review connects with ...

iPSCs in the cell therapy landscape: Interview with Elena Matsa

January 30, 2023

iPSCs in the cell therapy landscape: Interview with Elena Matsa

How has the cell therapy landscape evolved in the past ten years, particularly in regard to ...

Podcasts

Podcast: Genetic Engineering for Allogeneic Immunotherapy Development

December 8, 2023

Podcast: Genetic Engineering for Allogeneic Immunotherapy Development

"Cracking the genetic engineering for cell therapy case will enable us to start thinking about ...

Podcast: Allogeneic cell therapies and the immune system

September 21, 2023

Podcast: Allogeneic cell therapies and the immune system

"We're in an exciting age: the tools and techniques we now have open up the field of cell ...

Podcast: A Current look into adoptive cell therapies

August 3, 2023

Podcast: A Current look into adoptive cell therapies

"The future promise of allogeneic cell therapies"

Webinars

Webinar: Mastering challenges in iPSC-derived allogeneic cell drug product manufacturing

April 14, 2025

Webinar: Mastering challenges in iPSC-derived allogeneic cell drug product ...

Watch The Replay: From iPSCs to Functional NK Cell Therapy - A Client Journey

October 24, 2024

Watch The Replay: From iPSCs to Functional NK Cell Therapy - A Client ...

Discover how transitioning to iPSC-based allogeneic cell therapies can revolutionize modern ...

Webinar: Helping therapeutic developers to build cell therapy candidates

June 18, 2024

Webinar: Helping therapeutic developers to build cell therapy candidates

"Cellistic offers therapeutic developers a new path towards iPSC allogeneic cell therapy ...

Subscribe To Our
Newsletter

Keep up-to-date on our upcoming events, latest innovations and news from Cellistic.

Cellistic

Rue Edouard Belin 2
1435 Mont-Saint-Guibert
Belgium BE-Belgium-Flag

partnering@cellistic.com

  • Platforms
  • Allo Chassis™
  • Our Approach
  • News & Events
  • About
  • Contact
  • Privacy Policy
  • Cookie Policy
  • Team
  • Careers
X twitter x-twitter Linkedin